SAMBA data tracking Dashboard application for site monitoring of HIV test and treat programmes in Africa

现实世界诊断（DRW）正在推销一种简单、强大的即时核酸诊断平台SAMBA，该平台允许在发展中国家偏远、资源有限的环境和发达国家初级保健环境中进行复杂、高性能的检测。首批SAMBA检测是针对艾滋病毒的，将用于监测成人和婴儿的艾滋病毒治疗情况：一种用于测量艾滋病毒载量，另一种用于检测婴儿体内的艾滋病毒。在非洲，艾滋病治疗项目对于降低艾滋病死亡率和社会负担至关重要。由于世卫组织的建议和国际援助资金用于撒哈拉以南非洲的病毒载量监测和婴儿早期诊断，2017-2019年期间将有4.7亿美元用于艾滋病毒诊断采购。为了帮助非洲各国卫生部和msamdins Sans frontires等组织监测它们的艾滋病毒治疗方案，DRW正在提议开发一种创新的基于计算机的“云”应用程序（App）或“仪表盘”，它将结果发送到一个中心位置，并使组织能够分析数据并跟踪数据，以监测和跟踪结果，从而帮助艾滋病毒治疗方案更有效。理想情况下，该系统将与SAMBA一起使用，但也可以开发为允许将来自任何系统的患者结果导入数据库。

Diagnostics for the Real World (DRW) is marketing a simple, robust point-of-care nucleic acid diagnostic platform, called SAMBA, which allows complex, high-performance tests to be carried out in remote, resource-limited settings in developing countries and primary care settings in developed countries. The first SAMBA tests are for HIV and will be used to monitor HIV treatment in adults and infants: one to measure HIV viral load and one to detect HIV in infants. HIV treatment programs are critical in Africa to reduce the mortality and social burden of HIV there. Due to WHO recommendation and international aid funding for viral load monitoring and early infant diagnosis in sub-Saharan Africa, $470 million will be available between 2017-2019 for HIV diagnostic procurement. To help African Ministries of Health and organisations such as Médecins Sans Frontières to monitor their HIV treatment programs, DRW is proposing to develop an innovative “cloud” computer-based application (App) or “Dashboard” that would send results to a central location and give organisation the ability to analyse the data and track it for the purpose of monitoring and tracking results to help HIV treatment programs to be more effective. The system would ideally be used with SAMBA, but could be developed to allow patient results from any system to be imported into the database.